About Boston Scientific
Leading in minimally invasive therapies for arterial disease, venous disease and cancer.
Delivering Meaningful Innovation.
Advancing the Treatment of Arterial Disease. We’ve built a strong portfolio of products to serve this market and are uniquely positioned to provide physicians and hospital systems with a full tool box of solutions to treat patients.
Venous Therapies. Our venous portfolio offers a category-leading breadth of venous technologies including: venous stents, endovenous chemical ablation, ultrasound assisted clot dissolution devices, mechanical thrombectomy, and imaging catheters.
Tumor-Tackling Technologies. Our interventional oncology portfolio includes embolization technologies, and ablation technologies, all designed to prevent growth and cause tumor necrosis.
Delivering Meaningful Innovation.
Advancing the Treatment of Arterial Disease. We’ve built a strong portfolio of products to serve this market and are uniquely positioned to provide physicians and hospital systems with a full tool box of solutions to treat patients.
Venous Therapies. Our venous portfolio offers a category-leading breadth of venous technologies including: venous stents, endovenous chemical ablation, ultrasound assisted clot dissolution devices, mechanical thrombectomy, and imaging catheters.
Tumor-Tackling Technologies. Our interventional oncology portfolio includes embolization technologies, and ablation technologies, all designed to prevent growth and cause tumor necrosis.